Literature DB >> 17469093

Will targeting B cells be the answer for Sjögren's syndrome?

R John Looney.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17469093     DOI: 10.1002/art.22604

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  5 in total

Review 1.  Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies.

Authors:  A Vossenkämper; P M K Lutalo; J Spencer
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 2.  Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren's syndrome with rituximab: report of a case and review of the literature.

Authors:  Juan C Rueda; Carolina Duarte-Rey; Nohemi Casas
Journal:  Rheumatol Int       Date:  2009-01-11       Impact factor: 2.631

Review 3.  Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome.

Authors:  Kendrick Co Shih; Christie Nicole Lun; Vishal Jhanji; Bernard Yu-Hor Thong; Louis Tong
Journal:  J Inflamm (Lond)       Date:  2017-11-21       Impact factor: 4.981

Review 4.  B cell dysregulation in primary Sjögren's syndrome: A review.

Authors:  Hazim Mahmoud Ibrahem
Journal:  Jpn Dent Sci Rev       Date:  2019-10-21

5.  Is the blood B-cell subset profile diagnostic for Sjogren syndrome?

Authors:  A Binard; L Le Pottier; V Devauchelle-Pensec; A Saraux; P Youinou; J-O Pers
Journal:  Ann Rheum Dis       Date:  2008-09-09       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.